{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:28:42Z","timestamp":1792405722131,"version":"4.4.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-9966-33-37","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T15:06:53Z","timestamp":1398697613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["The multiple facets of drug resistance: one history, different approaches"],"prefix":"10.1186","volume":"33","author":[{"given":"Evandro Lu\u00eds","family":"Niero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Rocha-Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Lauand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Araujo","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Medina","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Rezende-Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Shiniti","family":"Urabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Arai","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Henrique","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00e1ucia Maria","family":"Machado-Santelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,28]]},"reference":[{"key":"823_CR1","first-page":"169","volume":"84","author":"P Christakis","year":"2011","unstructured":"Christakis P: The birth of chemotherapy at Yale. Bicentennial lecture series: Surgery Grand Round. Yale J Biol Med. 2011, 84: 169-172.","journal-title":"Yale J Biol Med"},{"key":"823_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2141.2006.06119.x","volume":"134","author":"DR Miller","year":"2006","unstructured":"Miller DR: A tribute to Sidney Farber\u2013 the father of modern chemotherapy. Br J Haematol. 2006, 134: 20-26. 10.1111\/j.1365-2141.2006.06119.x.","journal-title":"Br J Haematol"},{"key":"823_CR3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood.V18.4.431.431","volume":"18","author":"E Frei","year":"1961","unstructured":"Frei E, Freireich E, Gehan E: Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-mercaptopurine and methotrexate. Blood. 1961, 18: 431-454.","journal-title":"Blood"},{"key":"823_CR4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.V21.6.699.699","volume":"21","author":"E Freireich","year":"1963","unstructured":"Freireich E, Gehan E: The effect of 6-mercaptopurine on the duration of steroid-induced remissions in acute leukemia: a model for evaluation of other potentially useful therapy. Blood. 1963, 21: 699-716.","journal-title":"Blood"},{"key":"823_CR5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/blood.V26.5.642.642","volume":"26","author":"E Frei","year":"1965","unstructured":"Frei E, Karon M, Levin RH, Freireich EJ, Taylor RJ, Hananian J, Selawry O, Holland JF, Hoogstraten B, Wolman IJ, Abir E, Sawitsky A, Lee S, Mills SD, Burgert EO, Spurr CL, Patterson RB, Ebaugh FG, James GW, Moon JH: The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood. 1965, 26: 642-656.","journal-title":"Blood"},{"key":"823_CR6","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","volume":"68","author":"VT DeVita","year":"2008","unstructured":"DeVita VT, Chu E: A history of cancer chemotherapy. Cancer Res. 2008, 68: 8643-8653. 10.1158\/0008-5472.CAN-07-6611.","journal-title":"Cancer Res"},{"key":"823_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/169628a0","volume":"169","author":"LW LAW","year":"1952","unstructured":"LAW LW: Origin of the resistance of leukaemic cells to folic acid antagonists. Nature. 1952, 169: 628-629. 10.1038\/169628a0.","journal-title":"Nature"},{"key":"823_CR8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/genetics\/28.6.491","volume":"28","author":"SE Luria","year":"1943","unstructured":"Luria SE, Delbr\u00fcck M: Mutations of bacteria from virus sensitivity to virus resistance. Genetics. 1943, 28: 491-511.","journal-title":"Genetics"},{"key":"823_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1756-9966-32-45","volume":"32","author":"Y Chen","year":"2013","unstructured":"Chen Y, Liu H, Wu W, Li Y, Li J: Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis. J Exp Clin Cancer Res. 2013, 32: 45-10.1186\/1756-9966-32-45.","journal-title":"J Exp Clin Cancer Res"},{"key":"823_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-9966-31-6","volume":"31","author":"N Wang","year":"2012","unstructured":"Wang N, Zhang H, Yao Q, Wang Y, Dai S, Yang X: TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer. J Exp Clin Cancer Res. 2012, 31: 6-10.1186\/1756-9966-31-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"823_CR11","doi-asserted-by":"publisher","first-page":"e51764","DOI":"10.1371\/journal.pone.0051764","volume":"7","author":"G Wang","year":"2012","unstructured":"Wang G, Zhang J, Liu L, Sharma S, Dong Q: Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53\/Bcl-xl. PLoS One. 2012, 7: e51764-10.1371\/journal.pone.0051764.","journal-title":"PLoS One"},{"key":"823_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0163-7258(80)90048-0","volume":"8","author":"GJ Goldenberg","year":"1980","unstructured":"Goldenberg GJ, Begleiter A: Membrane transport of alkylating agents. Pharmacol Ther. 1980, 8: 237-274. 10.1016\/0163-7258(80)90048-0.","journal-title":"Pharmacol Ther"},{"key":"823_CR13","first-page":"47","volume":"5","author":"DW Fry","year":"1986","unstructured":"Fry DW, Jackson RC: Membrane transport alterations as a mechanism of resistance to anticancer agents. Cancer Surv. 1986, 5: 47-79.","journal-title":"Cancer Surv"},{"key":"823_CR14","first-page":"938","volume":"28","author":"D Kessel","year":"1968","unstructured":"Kessel D, Botterill V, Wodinsky I: Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response. Cancer Res. 1968, 28: 938-941.","journal-title":"Cancer Res"},{"key":"823_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","volume":"194","author":"PC Nowell","year":"1976","unstructured":"Nowell PC: The clonal evolution of tumor cell populations. Science. 1976, 194: 23-28. 10.1126\/science.959840.","journal-title":"Science"},{"key":"823_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994, 367: 645-648. 10.1038\/367645a0.","journal-title":"Nature"},{"key":"823_CR17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997, 3: 730-737. 10.1038\/nm0797-730.","journal-title":"Nat Med"},{"key":"823_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ: Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012, 10: 717-728. 10.1016\/j.stem.2012.05.007.","journal-title":"Cell Stem Cell"},{"key":"823_CR19","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-04-3502","volume":"65","author":"J Bai","year":"2005","unstructured":"Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP: Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Cancer Res. 2005, 65: 2344-2352. 10.1158\/0008-5472.CAN-04-3502.","journal-title":"Cancer Res"},{"key":"823_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/sj.bjc.6600753","volume":"88","author":"W Wang","year":"2003","unstructured":"Wang W, Cassidy J: Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells. Br J Cancer. 2003, 88: 624-629. 10.1038\/sj.bjc.6600753.","journal-title":"Br J Cancer"},{"key":"823_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ijc.10972","volume":"104","author":"W Wang","year":"2003","unstructured":"Wang W, McLeod HL, Cassidy J: Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines. Int J Cancer. 2003, 104: 504-511. 10.1002\/ijc.10972.","journal-title":"Int J Cancer"},{"key":"823_CR22","doi-asserted-by":"publisher","first-page":"241763","DOI":"10.1155\/2013\/241763","volume":"2013","author":"R Januchowski","year":"2013","unstructured":"Januchowski R, Wojtowicz K, Sujka-Kordowska P, Andrzejewska M, Zabel M: MDR gene expression analysis of six drug-resistant ovarian cancer cell lines. Biomed Res Int. 2013, 2013: 241763-","journal-title":"Biomed Res Int"},{"key":"823_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/(SICI)1097-0320(19971201)29:4<279::AID-CYTO3>3.0.CO;2-5","volume":"29","author":"A Krishan","year":"1997","unstructured":"Krishan A, Fitz CM, Andritsch I: Drug retention, efflux, and resistance in tumor cells. Cytometry. 1997, 29: 279-285. 10.1002\/(SICI)1097-0320(19971201)29:4<279::AID-CYTO3>3.0.CO;2-5.","journal-title":"Cytometry"},{"key":"823_CR24","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1073\/pnas.91.8.3176","volume":"91","author":"JM Aran","year":"1994","unstructured":"Aran JM, Gottesman MM, Pastan I: Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc Natl Acad Sci U S A. 1994, 91: 3176-3180. 10.1073\/pnas.91.8.3176.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"823_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1080\/15216540701736285","volume":"59","author":"M Munoz","year":"2007","unstructured":"Munoz M, Henderson M, Haber M, Norris M: Role of the MRP1\/ABCC1 multidrug transporter protein in cancer. IUBMB Life. 2007, 59: 752-757. 10.1080\/15216540701736285.","journal-title":"IUBMB Life"},{"key":"823_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00726-013-1553-6","volume":"46","author":"AA Abdulhussein","year":"2013","unstructured":"Abdulhussein AA, Wallace HM: Polyamines and membrane transporters. Amino Acids. 2013, 46: 655-660.","journal-title":"Amino Acids"},{"key":"823_CR27","doi-asserted-by":"publisher","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","volume":"84","author":"F Thiebaut","year":"1987","unstructured":"Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A. 1987, 84: 7735-7738. 10.1073\/pnas.84.21.7735.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"823_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1475-2867-12-21","volume":"12","author":"ND Jelly","year":"2012","unstructured":"Jelly ND, Hussain II, Eremin J, Eremin O, El-Sheemy M: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int. 2012, 12: 21-10.1186\/1475-2867-12-21.","journal-title":"Cancer Cell Int"},{"key":"823_CR29","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.7314\/APJCP.2012.13.6.2979","volume":"13","author":"F Kalalinia","year":"2012","unstructured":"Kalalinia F, Elahian F, Hassani M, Kasaeeian J, Behravan J: Phorbol ester TPA modulates chemoresistance in the drug sensitive breast cancer cell line MCF-7 by inducing expression of drug efflux transporter ABCG2. Asian Pac J Cancer Prev. 2012, 13: 2979-2984. 10.7314\/APJCP.2012.13.6.2979.","journal-title":"Asian Pac J Cancer Prev"},{"key":"823_CR30","doi-asserted-by":"publisher","first-page":"e44312","DOI":"10.1371\/journal.pone.0044312","volume":"7","author":"PA Ferreira","year":"2012","unstructured":"Ferreira PA, Ruela-de-Sousa RR, Queiroz KCS, Souza ACS, Milani R, Pilli RA, Peppelenbosch MP, den Hertog J, Ferreira CV: Knocking down low molecular weight protein tyrosine phosphatase (LMW-PTP) reverts chemoresistance through inactivation of Src and Bcr-Abl proteins. PLoS One. 2012, 7: e44312-10.1371\/journal.pone.0044312.","journal-title":"PLoS One"},{"key":"823_CR31","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/annonc\/mdr512","volume":"23","author":"JG Van Oosterwijk","year":"2012","unstructured":"Van Oosterwijk JG, Herpers B, Meijer D, Briaire-de Bruijn IH, Cleton-Jansen AM, Gelderblom H, van de Water B, Bov\u00e9e JVMG: Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance. Ann Oncol. 2012, 23: 1617-1626. 10.1093\/annonc\/mdr512.","journal-title":"Ann Oncol"},{"key":"823_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/147323001204000204","volume":"40","author":"H Sui","year":"2012","unstructured":"Sui H, Fan Z-Z, Li Q: Signal transduction pathways and transcriptional mechanisms of ABCB1\/Pgp-mediated multiple drug resistance in human cancer cells. J Int Med Res. 2012, 40: 426-435. 10.1177\/147323001204000204.","journal-title":"J Int Med Res"},{"key":"823_CR33","first-page":"119","volume":"21","author":"S Z\u00f6chbauer-M\u00fcller","year":"2001","unstructured":"Z\u00f6chbauer-M\u00fcller S, Filipits M, Rudas M, Brunner R, Krajnik G, Suchomel R, Schmid K, Pirker R: P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients. Anticancer Res. 2001, 21: 119-124.","journal-title":"Anticancer Res"},{"key":"823_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1014594825502","volume":"19","author":"MA dit Faute","year":"2002","unstructured":"dit Faute MA, Laurent L, Ploton D, Poupon M-F, Jardillier J-C, Bobichon H: Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant. Clin Exp Metastasis. 2002, 19: 161-168. 10.1023\/A:1014594825502.","journal-title":"Clin Exp Metastasis"},{"key":"823_CR35","doi-asserted-by":"publisher","first-page":"e90022","DOI":"10.1371\/journal.pone.0090022","volume":"9","author":"Y Shi","year":"2014","unstructured":"Shi Y, Liu C, Liu X, Tang DG, Wang J: The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells. PLoS One. 2014, 9: e90022-10.1371\/journal.pone.0090022.","journal-title":"PLoS One"},{"key":"823_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bcp.2013.10.017","volume":"87","author":"SM Markova","year":"2014","unstructured":"Markova SM, Kroetz DL: ABCC4 is regulated by microRNA-124a and microRNA-506. Biochem Pharmacol. 2014, 87: 515-522. 10.1016\/j.bcp.2013.10.017.","journal-title":"Biochem Pharmacol"},{"key":"823_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10549-013-2607-x","volume":"139","author":"X Jiao","year":"2013","unstructured":"Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M: MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP\/ABCG2). Breast Cancer Res Treat. 2013, 139: 717-730. 10.1007\/s10549-013-2607-x.","journal-title":"Breast Cancer Res Treat"},{"key":"823_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0014-5793(98)00061-1","volume":"423","author":"VP Skulachev","year":"1998","unstructured":"Skulachev VP: Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett. 1998, 423: 275-280. 10.1016\/S0014-5793(98)00061-1.","journal-title":"FEBS Lett"},{"key":"823_CR39","first-page":"3000","volume":"47","author":"AM Fichtinger-Schepman","year":"1987","unstructured":"Fichtinger-Schepman AM, van Oosterom AT, Lohman PH, Berends F: cis-Diamminedichloroplatinum (II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum (II). Cancer Res. 1987, 47: 3000-3004.","journal-title":"Cancer Res"},{"key":"823_CR40","first-page":"718","volume":"47","author":"E Reed","year":"1987","unstructured":"Reed E, Litterst CL, Thill CC, Yuspa SH, Poirier MC: cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats. Cancer Res. 1987, 47: 718-722.","journal-title":"Cancer Res"},{"key":"823_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1756-9966-30-91","volume":"30","author":"N Eckstein","year":"2011","unstructured":"Eckstein N: Platinum resistance in breast and ovarian cancer cell lines. J Exp Clin Cancer Res. 2011, 30: 91-10.1186\/1756-9966-30-91.","journal-title":"J Exp Clin Cancer Res"},{"key":"823_CR42","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1073\/pnas.78.9.5608","volume":"78","author":"M De Brabander","year":"1981","unstructured":"De Brabander M, Geuens G, Nuydens R, Willebrords R, De Mey J: Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc Natl Acad Sci U S A. 1981, 78: 5608-5612. 10.1073\/pnas.78.9.5608.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"823_CR43","first-page":"4355","volume":"54","author":"BH Long","year":"1994","unstructured":"Long BH, Fairchild CR: Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase. Cancer Res. 1994, 54: 4355-4361.","journal-title":"Cancer Res"},{"key":"823_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s000180050270","volume":"55","author":"RR Wallace-Brodeur","year":"1999","unstructured":"Wallace-Brodeur RR, Lowe SW: Clinical implications of p53 mutations. Cell Mol Life Sci. 1999, 55: 64-75. 10.1007\/s000180050270.","journal-title":"Cell Mol Life Sci"},{"key":"823_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1471-4914(01)02013-5","volume":"7","author":"K Satyamoorthy","year":"2001","unstructured":"Satyamoorthy K, Bogenrieder T, Herlyn M: No longer a molecular black box\u2013new clues to apoptosis and drug resistance in melanoma. Trends Mol Med. 2001, 7: 191-194. 10.1016\/S1471-4914(01)02013-5.","journal-title":"Trends Mol Med"},{"key":"823_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li Z-W: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002, 2: 301-310. 10.1038\/nrc780.","journal-title":"Nat Rev Cancer"},{"key":"823_CR47","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0022-3565(24)38293-X","volume":"289","author":"DH Lee","year":"1999","unstructured":"Lee DH, Macintyre JP, Taylor GR, Wang E, Plante RK, Tam SS, Pope BL, Lau CY: Tepoxalin enhances the activity of an antioxidant, pyrrolidine dithiocarbamate, in attenuating tumor necrosis factor alpha-induced apoptosis in WEHI 164 cells. J Pharmacol Exp Ther. 1999, 289: 1465-1471.","journal-title":"J Pharmacol Exp Ther"},{"key":"823_CR48","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL: Activators and target genes of Rel\/NF-kappaB transcription factors. Oncogene. 1999, 18: 6853-6866. 10.1038\/sj.onc.1203239.","journal-title":"Oncogene"},{"key":"823_CR49","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jss.2003.11.023","volume":"120","author":"R Voboril","year":"2004","unstructured":"Voboril R, Hochwald SN, Li J, Brank A, Weberova J, Wessels F, Moldawer LL, Camp ER, MacKay SLD: Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil\/folinic acid in colon cancer. J Surg Res. 2004, 120: 178-188. 10.1016\/j.jss.2003.11.023.","journal-title":"J Surg Res"},{"key":"823_CR50","doi-asserted-by":"publisher","first-page":"10553","DOI":"10.1158\/0008-5472.CAN-06-2333","volume":"66","author":"BF El-Rayes","year":"2006","unstructured":"El-Rayes BF, Ali S, Ali IF, Philip PA, Abbruzzese J, Sarkar FH: Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. Cancer Res. 2006, 66: 10553-10559. 10.1158\/0008-5472.CAN-06-2333.","journal-title":"Cancer Res"},{"key":"823_CR51","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/sj.onc.1206390","volume":"22","author":"A Arlt","year":"2003","unstructured":"Arlt A, Gehrz A, M\u00fcerk\u00f6ster S, Vorndamm J, Kruse M, F\u00f6lsch UR, Sch\u00e4fer H: Role of NF-kappaB and Akt\/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene. 2003, 22: 3243-3251. 10.1038\/sj.onc.1206390.","journal-title":"Oncogene"},{"key":"823_CR52","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1158\/0008-5472.CAN-09-0838","volume":"69","author":"S Banerjee","year":"2009","unstructured":"Banerjee S, Wang Z, Kong D, Sarkar FH: 3,3\u2032-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer. Cancer Res. 2009, 69: 5592-5600. 10.1158\/0008-5472.CAN-09-0838.","journal-title":"Cancer Res"},{"key":"823_CR53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ijc.10963","volume":"104","author":"S M\u00fcerk\u00f6ster","year":"2003","unstructured":"M\u00fcerk\u00f6ster S, Arlt A, Witt M, Gehrz A, Haye S, March C, Grohmann F, Wegehenkel K, Kalthoff H, F\u00f6lsch UR, Sch\u00e4fer H: Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. Int J Cancer. 2003, 104: 469-476. 10.1002\/ijc.10963.","journal-title":"Int J Cancer"},{"key":"823_CR54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1517\/14728222.2011.566216","volume":"15","author":"J Long","year":"2011","unstructured":"Long J, Zhang Y, Yu X, Yang J, LeBrun DG, Chen C, Yao Q, Li M: Overcoming drug resistance in pancreatic cancer. Expert Opin Ther Targets. 2011, 15: 817-828. 10.1517\/14728222.2011.566216.","journal-title":"Expert Opin Ther Targets"},{"key":"823_CR55","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00432-012-1152-z","volume":"138","author":"Y-W Wang","year":"2012","unstructured":"Wang Y-W, Wang S-J, Zhou Y-N, Pan S-H, Sun B: Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-\u03baB and nuclear factor-\u03baB-regulated gene products in pancreatic cancer both in vitro and in vivo. J Cancer Res Clin Oncol. 2012, 138: 785-797. 10.1007\/s00432-012-1152-z.","journal-title":"J Cancer Res Clin Oncol"},{"key":"823_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1631\/jzus.2005.B0028","volume":"6","author":"G Xiao","year":"2005","unstructured":"Xiao G, Wei J: Effects of beta-Aescin on the expression of nuclear factor-kappaB and tumor necrosis factor-alpha after traumatic brain injury in rats. J Zhejiang Univ Sci B. 2005, 6: 28-32.","journal-title":"J Zhejiang Univ Sci B"},{"key":"823_CR57","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1124\/mol.109.062760","volume":"77","author":"KB Harikumar","year":"2010","unstructured":"Harikumar KB, Sung B, Pandey MK, Guha S, Krishnan S, Aggarwal BB: Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway. Mol Pharmacol. 2010, 77: 818-827. 10.1124\/mol.109.062760.","journal-title":"Mol Pharmacol"},{"key":"823_CR58","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1158\/1535-7163.MCT-05-0495","volume":"5","author":"JMR Patlolla","year":"2006","unstructured":"Patlolla JMR, Raju J, Swamy MV, Rao CV: Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1\/cip1) in colon cancer cells. Mol Cancer Ther. 2006, 5: 1459-1466. 10.1158\/1535-7163.MCT-05-0495.","journal-title":"Mol Cancer Ther"},{"key":"823_CR59","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1124\/jpet.110.165498","volume":"334","author":"SM Tan","year":"2010","unstructured":"Tan SM, Li F, Rajendran P, Kumar AP, Hui KM, Sethi G: Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3\/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. J Pharmacol Exp Ther. 2010, 334: 285-293. 10.1124\/jpet.110.165498.","journal-title":"J Pharmacol Exp Ther"},{"key":"823_CR60","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/mc.20762","volume":"50","author":"DB Ji","year":"2011","unstructured":"Ji DB, Xu B, Liu JT, Ran FX, Cui JR: \u03b2-Escin sodium inhibits inducible nitric oxide synthase expression via downregulation of the JAK\/STAT pathway in A549 cells. Mol Carcinog. 2011, 50: 945-960. 10.1002\/mc.20762.","journal-title":"Mol Carcinog"},{"key":"823_CR61","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/ptr.3435","volume":"25","author":"D-Y Shen","year":"2011","unstructured":"Shen D-Y, Kang J-H, Song W, Zhang W-Q, Li W-G, Zhao Y, Chen Q-X: Apoptosis of human cholangiocarcinoma cell lines induced by \u03b2-escin through mitochondrial caspase-dependent pathway. Phytother Res. 2011, 25: 1519-1526. 10.1002\/ptr.3435.","journal-title":"Phytother Res"},{"key":"823_CR62","doi-asserted-by":"publisher","first-page":"e54193","DOI":"10.1371\/journal.pone.0054193","volume":"8","author":"MP Barr","year":"2013","unstructured":"Barr MP, Gray SG, Hoffmann AC, Hilger RA, Thomale J, O\u2019Flaherty JD, Fennell DA, Richard D, O\u2019Leary JJ, O\u2019Byrne KJ: Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. PLoS One. 2013, 8: e54193-10.1371\/journal.pone.0054193.","journal-title":"PLoS One"},{"key":"823_CR63","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1158\/0008-5472.CAN-04-4604","volume":"65","author":"Y Li","year":"2005","unstructured":"Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH: Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res. 2005, 65: 6934-6942. 10.1158\/0008-5472.CAN-04-4604.","journal-title":"Cancer Res"},{"key":"823_CR64","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1477-7827-1-66","volume":"1","author":"M Fraser","year":"2003","unstructured":"Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK: Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reprod Biol Endocrinol. 2003, 1: 66-10.1186\/1477-7827-1-66.","journal-title":"Reprod Biol Endocrinol"},{"key":"823_CR65","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.1158\/1078-0432.CCR-04-0958","volume":"10","author":"S Mabuchi","year":"2004","unstructured":"Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Kawagoe J, Takahashi K, Yada-Hashimoto N, Seino-Noda H, Sakata M, Motoyama T, Kurachi H, Testa JR, Tasaka K, Murata Y: Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clin Cancer Res. 2004, 10: 7645-7654. 10.1158\/1078-0432.CCR-04-0958.","journal-title":"Clin Cancer Res"},{"key":"823_CR66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrc1588","volume":"5","author":"C Nakanishi","year":"2005","unstructured":"Nakanishi C, Toi M: Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer. 2005, 5: 297-309. 10.1038\/nrc1588.","journal-title":"Nat Rev Cancer"},{"key":"823_CR67","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1196\/annals.1397.012","volume":"1095","author":"S-H Kim","year":"2007","unstructured":"Kim S-H, Juhnn Y-S, Song Y-S: Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells. Ann N Y Acad Sci. 2007, 1095: 82-89. 10.1196\/annals.1397.012.","journal-title":"Ann N Y Acad Sci"},{"key":"823_CR68","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.1158\/1078-0432.CCR-05-1192","volume":"11","author":"BB Aggarwal","year":"2005","unstructured":"Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE: Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res. 2005, 11: 7490-7498. 10.1158\/1078-0432.CCR-05-1192.","journal-title":"Clin Cancer Res"},{"key":"823_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2004.10.051","volume":"224","author":"M Notarbartolo","year":"2005","unstructured":"Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D\u2019Alessandro N: Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett. 2005, 224: 53-65. 10.1016\/j.canlet.2004.10.051.","journal-title":"Cancer Lett"},{"key":"823_CR70","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1158\/0008-5472.CAN-06-3066","volume":"67","author":"M Li","year":"2007","unstructured":"Li M, Zhang Z, Hill DL, Wang H, Zhang R: Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K\/mTOR\/ETS2 pathway. Cancer Res. 2007, 67: 1988-1996. 10.1158\/0008-5472.CAN-06-3066.","journal-title":"Cancer Res"},{"key":"823_CR71","doi-asserted-by":"publisher","first-page":"839298","DOI":"10.1155\/2012\/839298","volume":"2012","author":"L Zambonin","year":"2012","unstructured":"Zambonin L, Caliceti C, Vieceli Dalla Sega F, Fiorentini D, Hrelia S, Landi L, Prata C: Dietary phenolic acids act as effective antioxidants in membrane models and in cultured cells, exhibiting proapoptotic effects in leukaemia cells. Oxid Med Cell Longev. 2012, 2012: 839298-","journal-title":"Oxid Med Cell Longev"},{"key":"823_CR72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1756-9966-32-31","volume":"32","author":"ELDO Niero","year":"2013","unstructured":"Niero ELDO, Machado-Santelli GM: Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells. J Exp Clin Cancer Res. 2013, 32: 31-10.1186\/1756-9966-32-31.","journal-title":"J Exp Clin Cancer Res"},{"key":"823_CR73","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3892\/or.2012.2163","volume":"29","author":"A Tomizawa","year":"2013","unstructured":"Tomizawa A, Kanno S, Osanai Y, Goto A, Sato C, Yomogida S, Ishikawa M: Induction of apoptosis by a potent caffeic acid derivative, caffeic acid undecyl ester, is mediated by mitochondrial damage in NALM-6 human B cell leukemia cells. Oncol Rep. 2013, 29: 425-429.","journal-title":"Oncol Rep"},{"key":"823_CR74","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1093\/carcin\/bgs302","volume":"33","author":"Y-I Yang","year":"2012","unstructured":"Yang Y-I, Lee K-T, Park H-J, Kim TJ, Choi YS, Shih I-M, Choi J-H: Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NF\u03baB pathway. Carcinogenesis. 2012, 33: 2488-2498. 10.1093\/carcin\/bgs302.","journal-title":"Carcinogenesis"},{"key":"823_CR75","doi-asserted-by":"publisher","first-page":"8910","DOI":"10.1158\/0008-5472.CAN-09-1543","volume":"69","author":"E-SA Arafa","year":"2009","unstructured":"Arafa E-SA, Zhu Q, Barakat BM, Wani G, Zhao Q, El-Mahdy MA, Wani AA: Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase\/Akt signaling pathway. Cancer Res. 2009, 69: 8910-8917. 10.1158\/0008-5472.CAN-09-1543.","journal-title":"Cancer Res"},{"key":"823_CR76","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"S Datta","year":"1999","unstructured":"Datta S, Brunet A, Greenberg M: Cellular survival: a play in three Akts. Genes Dev. 1999, 13: 2905-2927. 10.1101\/gad.13.22.2905.","journal-title":"Genes Dev"},{"key":"823_CR77","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1038\/sj.onc.1203598","volume":"19","author":"ZQ Yuan","year":"2000","unstructured":"Yuan ZQ, Sun M, Feldman RI, Wang G, Ma X, Jiang C, Coppola D, Nicosia SV, Cheng JQ: Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase\/Akt pathway in human ovarian cancer. Oncogene. 2000, 19: 2324-2330. 10.1038\/sj.onc.1203598.","journal-title":"Oncogene"},{"key":"823_CR78","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0002-9440(10)61714-2","volume":"159","author":"M Sun","year":"2001","unstructured":"Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma XL, Shelley SA, Jove R, Tsichlis PN, Nicosia SV, Cheng JQ: AKT1\/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol. 2001, 159: 431-437. 10.1016\/S0002-9440(10)61714-2.","journal-title":"Am J Pathol"},{"key":"823_CR79","first-page":"5985","volume":"61","author":"M Sun","year":"2001","unstructured":"Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV, Cheng JQ: Phosphatidylinositol-3-OH Kinase (PI3K)\/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res. 2001, 61: 5985-5991.","journal-title":"Cancer Res"},{"key":"823_CR80","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1158\/0008-5472.CAN-08-4055","volume":"69","author":"ML Sos","year":"2009","unstructured":"Sos ML, Koker M, Weir BA, Heynck S, Rabinovsky R, Zander T, Seeger JM, Weiss J, Fischer F, Frommolt P, Michel K, Peifer M, Mermel C, Girard L, Peyton M, Gazdar AF, Minna JD, Garraway LA, Kashkar H, Pao W, Meyerson M, Thomas RK: PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. Cancer Res. 2009, 69: 3256-3261. 10.1158\/0008-5472.CAN-08-4055.","journal-title":"Cancer Res"},{"key":"823_CR81","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1158\/1535-7163.MCT-09-1171","volume":"9","author":"NA O\u2019Brien","year":"2010","unstructured":"O\u2019Brien NA, Browne BC, Chow L, Wang Y, Ginther C, Arboleda J, Duffy MJ, Crown J, O\u2019Donovan N, Slamon DJ: Activated phosphoinositide 3-kinase\/AKT signaling confers resistance to trastuzumab but not lapatinib. Mol Cancer Ther. 2010, 9: 1489-1502. 10.1158\/1535-7163.MCT-09-1171.","journal-title":"Mol Cancer Ther"},{"key":"823_CR82","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1124\/jpet.110.175786","volume":"337","author":"K-F Chen","year":"2011","unstructured":"Chen K-F, Chen H-L, Tai W-T, Feng W-C, Hsu C-H, Chen P-J, Cheng A-L: Activation of phosphatidylinositol 3-kinase\/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharmacol Exp Ther. 2011, 337: 155-161. 10.1124\/jpet.110.175786.","journal-title":"J Pharmacol Exp Ther"},{"key":"823_CR83","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1038\/onc.2011.596","volume":"31","author":"F-C Lin","year":"2012","unstructured":"Lin F-C, Liu Y-P, Lai C-H, Shan Y-S, Cheng H-C, Hsu P-I, Lee C-H, Lee Y-C, Wang H-Y, Wang C-H, Cheng JQ, Hsiao M, Lu P-J: RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells. Oncogene. 2012, 31: 4302-4316. 10.1038\/onc.2011.596.","journal-title":"Oncogene"},{"key":"823_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/273086","volume":"45","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Wang R, Song H-Z, Pan B-Z, Zhang Y-W, Chen L-B: Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway. Int J Biochem Cell Biol. 2013, 45: 1-10. 10.1016\/j.biocel.2012.10.008.","journal-title":"Int J Biochem Cell Biol"},{"key":"823_CR85","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12013-012-9456-9","volume":"66","author":"B-N Liu","year":"2013","unstructured":"Liu B-N, Yan H-Q, Wu X, Pan Z-H, Zhu Y, Meng Z-W, Zhou Q-H, Xu K: Apoptosis induced by benzyl isothiocyanate in gefitinib-resistant lung cancer cells is associated with Akt\/MAPK pathways and generation of reactive oxygen species. Cell Biochem Biophys. 2013, 66: 81-92. 10.1007\/s12013-012-9456-9.","journal-title":"Cell Biochem Biophys"},{"key":"823_CR86","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/carcin\/bgt108","volume":"34","author":"A-M Gao","year":"2013","unstructured":"Gao A-M, Ke Z-P, Wang J-N, Yang J-Y, Chen S-Y, Chen H: Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402\/ADM cells to doxorubicin via inhibiting PI3K\/Akt\/Nrf2 pathway. Carcinogenesis. 2013, 34: 1806-1814. 10.1093\/carcin\/bgt108.","journal-title":"Carcinogenesis"},{"key":"823_CR87","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994, 124: 619-626. 10.1083\/jcb.124.4.619.","journal-title":"J Cell Biol"},{"key":"823_CR88","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ijc.2910030517","volume":"3","author":"M Stoker","year":"1968","unstructured":"Stoker M, O\u2019Neill C, Berryman S, Waxman V: Anchorage and growth regulation in normal and virus-transformed cells. Int J Cancer. 1968, 3: 683-693. 10.1002\/ijc.2910030517.","journal-title":"Int J Cancer"},{"key":"823_CR89","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/430973a","volume":"430","author":"LA Liotta","year":"2004","unstructured":"Liotta LA, Kohn E: Anoikis: cancer and the homeless cell. Nature. 2004, 430: 973-974. 10.1038\/430973a.","journal-title":"Nature"},{"key":"823_CR90","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0955-0674(00)00251-9","volume":"13","author":"SM Frisch","year":"2001","unstructured":"Frisch SM, Screaton RA: Anoikis mechanisms. Curr Opin Cell Biol. 2001, 13: 555-562. 10.1016\/S0955-0674(00)00251-9.","journal-title":"Curr Opin Cell Biol"},{"key":"823_CR91","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1128\/MCB.21.19.6529-6536.2001","volume":"21","author":"SS Martin","year":"2001","unstructured":"Martin SS, Leder P: Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2. Mol Cell Biol. 2001, 21: 6529-6536. 10.1128\/MCB.21.19.6529-6536.2001.","journal-title":"Mol Cell Biol"},{"key":"823_CR92","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/sj.bjc.6600566","volume":"87","author":"M Schmidt","year":"2002","unstructured":"Schmidt M, H\u00f6velmann S, Beckers TL, Ho S: A novel form of constitutively active farnesylated Akt1 prevents mammary epithelial cells from anoikis and suppresses chemotherapy-induced apoptosis. Br J Cancer. 2002, 87: 924-932. 10.1038\/sj.bjc.6600566.","journal-title":"Br J Cancer"},{"key":"823_CR93","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-04-0424","volume":"64","author":"MS Duxbury","year":"2004","unstructured":"Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE: A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res. 2004, 64: 3987-3993. 10.1158\/0008-5472.CAN-04-0424.","journal-title":"Cancer Res"},{"key":"823_CR94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2407-5-39","volume":"5","author":"CM D\u00edaz-Montero","year":"2005","unstructured":"D\u00edaz-Montero CM, McIntyre BW: Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents. BMC Cancer. 2005, 5: 39-10.1186\/1471-2407-5-39.","journal-title":"BMC Cancer"},{"key":"823_CR95","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1158\/1535-7163.MCT-12-0463","volume":"11","author":"DM Cittelly","year":"2012","unstructured":"Cittelly DM, Dimitrova I, Howe EN, Cochrane DR, Jean A, Spoelstra NS, Post MD, Lu X, Broaddus RR, Spillman MA, Richer JK: Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Mol Cancer Ther. 2012, 11: 2556-2565. 10.1158\/1535-7163.MCT-12-0463.","journal-title":"Mol Cancer Ther"},{"key":"823_CR96","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1146\/annurev.ge.22.120188.003215","volume":"22","author":"S Lindquist","year":"1988","unstructured":"Lindquist S, Craig EA: The heat-shock proteins. Annu Rev Genet. 1988, 22: 631-677. 10.1146\/annurev.ge.22.120188.003215.","journal-title":"Annu Rev Genet"},{"key":"823_CR97","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/370111a0","volume":"370","author":"J Frydman","year":"1994","unstructured":"Frydman J, Nimmesgern E, Ohtsuka K, Hartl FU: Folding of nascent polypeptide chains in a high molecular mass assembly with molecular chaperones. Nature. 1994, 370: 111-117. 10.1038\/370111a0.","journal-title":"Nature"},{"key":"823_CR98","doi-asserted-by":"publisher","first-page":"11873","DOI":"10.1074\/jbc.M111445200","volume":"277","author":"MP Hern\u00e1ndez","year":"2002","unstructured":"Hern\u00e1ndez MP, Chadli A, Toft DO: HSP40 binding is the first step in the HSP90 chaperoning pathway for the progesterone receptor. J Biol Chem. 2002, 277: 11873-11881. 10.1074\/jbc.M111445200.","journal-title":"J Biol Chem"},{"key":"823_CR99","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bmcl.2013.11.034","volume":"24","author":"C-H Jeong","year":"2014","unstructured":"Jeong C-H, Park HB, Jang WJ, Jung SH, Seo YH: Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC). Bioorg Med Chem Lett. 2014, 24: 224-227. 10.1016\/j.bmcl.2013.11.034.","journal-title":"Bioorg Med Chem Lett"},{"key":"823_CR100","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1158\/2159-8290.CD-12-0440","volume":"3","author":"J Sang","year":"2013","unstructured":"Sang J, Acquaviva J, Friedland JC, Smith DL, Sequeira M, Zhang C, Jiang Q, Xue L, Lovly CM, Jimenez J-P, Shaw AT, Doebele RC, He S, Bates RC, Camidge DR, Morris SW, El-Hariry I, Proia DA: Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer. Cancer Discov. 2013, 3: 430-443. 10.1158\/2159-8290.CD-12-0440.","journal-title":"Cancer Discov"},{"key":"823_CR101","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/cas.12237","volume":"104","author":"N Ono","year":"2013","unstructured":"Ono N, Yamazaki T, Tsukaguchi T, Fujii T, Sakata K, Suda A, Tsukuda T, Mio T, Ishii N, Kondoh O, Aoki Y: Enhanced antitumor activity of erlotinib in combination with the Hsp90 inhibitor CH5164840 against non-small-cell lung cancer. Cancer Sci. 2013, 104: 1346-1352. 10.1111\/cas.12237.","journal-title":"Cancer Sci"},{"key":"823_CR102","first-page":"1356","volume":"2013","author":"C Gallerne","year":"1833","unstructured":"Gallerne C, Prola A, Lemaire C: Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2. Biochim Biophys Acta. 1833, 2013: 1356-1366.","journal-title":"Biochim Biophys Acta"},{"key":"823_CR103","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/35019501","volume":"2","author":"HM Beere","year":"2000","unstructured":"Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM, Green DR: Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol. 2000, 2: 469-475. 10.1038\/35019501.","journal-title":"Nat Cell Biol"},{"key":"823_CR104","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/35019510","volume":"2","author":"A Saleh","year":"2000","unstructured":"Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES: Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol. 2000, 2: 476-483. 10.1038\/35019510.","journal-title":"Nat Cell Biol"},{"key":"823_CR105","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1200\/JCO.2005.12.085","volume":"23","author":"JL Grem","year":"2005","unstructured":"Grem JL, Morrison G, Guo X-D, Agnew E, Takimoto CH, Thomas R, Szabo E, Grochow L, Grollman F, Hamilton JM, Neckers L, Wilson RH: Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors. J Clin Oncol. 2005, 23: 1885-1893. 10.1200\/JCO.2005.12.085.","journal-title":"J Clin Oncol"},{"key":"823_CR106","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1021\/bi026735t","volume":"42","author":"H Whetstone","year":"2003","unstructured":"Whetstone H, Lingwood C: 3\u2032Sulfogalactolipid binding specifically inhibits Hsp70 ATPase activity in vitro. Biochemistry. 2003, 42: 1611-1617. 10.1021\/bi026735t.","journal-title":"Biochemistry"},{"key":"823_CR107","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1158\/0008-5472.CAN-10-1443","volume":"71","author":"A-L R\u00e9role","year":"2011","unstructured":"R\u00e9role A-L, Gobbo J, De Thonel A, Schmitt E, Pais de Barros JP, Hammann A, Lanneau D, Fourmaux E, Deminov O, Micheau O, Lagrost L, Colas P, Kroemer G, Garrido C: Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy. Cancer Res. 2011, 71: 484-495. 10.1158\/0008-5472.CAN-10-1443.","journal-title":"Cancer Res"},{"key":"823_CR108","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1038\/cddis.2013.550","volume":"5","author":"H Endo","year":"2014","unstructured":"Endo H, Yano M, Okumura Y, Kido H: Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70. Cell Death Dis. 2014, 5: e1027-10.1038\/cddis.2013.550.","journal-title":"Cell Death Dis"},{"key":"823_CR109","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2011.08.019","volume":"312","author":"JN Sterrenberg","year":"2011","unstructured":"Sterrenberg JN, Blatch GL, Edkins AL: Human DNAJ in cancer and stem cells. Cancer Lett. 2011, 312: 129-142. 10.1016\/j.canlet.2011.08.019.","journal-title":"Cancer Lett"},{"key":"823_CR110","doi-asserted-by":"publisher","first-page":"27828","DOI":"10.1074\/jbc.M303417200","volume":"278","author":"MJ Rane","year":"2003","unstructured":"Rane MJ, Pan Y, Singh S, Powell DW, Wu R, Cummins T, Chen Q, McLeish KR, Klein JB: Heat shock protein 27 controls apoptosis by regulating Akt activation. J Biol Chem. 2003, 278: 27828-27835. 10.1074\/jbc.M303417200.","journal-title":"J Biol Chem"},{"key":"823_CR111","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.cellsig.2013.11.033","volume":"26","author":"S Qi","year":"2014","unstructured":"Qi S, Xin Y, Qi Z, Xu Y, Diao Y, Lan L, Luo L, Yin Z: HSP27 phosphorylation modulates TRAIL-induced activation of Src-Akt\/ERK signaling through interaction with \u03b2-arrestin2. Cell Signal. 2014, 26: 594-602. 10.1016\/j.cellsig.2013.11.033.","journal-title":"Cell Signal"},{"key":"823_CR112","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-9966-31-14","volume":"31","author":"A Kim","year":"2012","unstructured":"Kim A, Ueda Y, Naka T, Enomoto T: Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res. 2012, 31: 14-10.1186\/1756-9966-31-14.","journal-title":"J Exp Clin Cancer Res"},{"key":"823_CR113","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/cncr.25599","volume":"117","author":"H-S Hsu","year":"2011","unstructured":"Hsu H-S, Lin J-H, Huang W-C, Hsu T-W, Su K, Chiou S-H, Tsai Y-T, Hung S-C: Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer. 2011, 117: 1516-1528. 10.1002\/cncr.25599.","journal-title":"Cancer"},{"key":"823_CR114","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.bmcl.2013.02.014","volume":"23","author":"JR McConnell","year":"2013","unstructured":"McConnell JR, McAlpine SR: Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets. Bioorg Med Chem Lett. 2013, 23: 1923-1928. 10.1016\/j.bmcl.2013.02.014.","journal-title":"Bioorg Med Chem Lett"},{"key":"823_CR115","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1021\/ar7000827","volume":"41","author":"GD Prestwich","year":"2008","unstructured":"Prestwich GD: Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Acc Chem Res. 2008, 41: 139-148. 10.1021\/ar7000827.","journal-title":"Acc Chem Res"},{"key":"823_CR116","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1126\/science.1064829","volume":"294","author":"E Cukierman","year":"2001","unstructured":"Cukierman E, Pankov R, Stevens DR, Yamada KM: Taking cell-matrix adhesions to the third dimension. Science. 2001, 294: 1708-1712. 10.1126\/science.1064829.","journal-title":"Science"},{"key":"823_CR117","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1469-7580.2007.00778.x","volume":"211","author":"M Bokhari","year":"2007","unstructured":"Bokhari M, Carnachan RJ, Cameron NR, Przyborski SA: Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge. J Anat. 2007, 211: 567-576.","journal-title":"J Anat"},{"key":"823_CR118","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1073\/pnas.79.15.4672","volume":"79","author":"HG Hall","year":"1982","unstructured":"Hall HG, Farson DA, Bissell MJ: Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc Natl Acad Sci U S A. 1982, 79: 4672-4676. 10.1073\/pnas.79.15.4672.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"823_CR119","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1042\/CBI20090024","volume":"34","author":"JB Do Amaral","year":"2010","unstructured":"Do Amaral JB, Urabayashi MS, Machado-Santelli GM: Cell death and lumen formation in spheroids of MCF-7 cells. Cell Biol Int. 2010, 34: 267-274. 10.1042\/CBI20090024.","journal-title":"Cell Biol Int"},{"key":"823_CR120","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1089\/ten.tec.2011.0260","volume":"17","author":"JB Do Amaral","year":"2011","unstructured":"Do Amaral JB, Rezende-Teixeira P, Freitas VM, Machado-Santelli GM: MCF-7 cells as a three-dimensional model for the study of human breast cancer. Tissue Eng Part C Methods. 2011, 17: 1097-1107. 10.1089\/ten.tec.2011.0260.","journal-title":"Tissue Eng Part C Methods"},{"key":"823_CR121","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00441-012-1441-5","volume":"352","author":"H Page","year":"2013","unstructured":"Page H, Flood P, Reynaud EG: Three-dimensional tissue cultures: current trends and beyond. Cell Tissue Res. 2013, 352: 123-131. 10.1007\/s00441-012-1441-5.","journal-title":"Cell Tissue Res"},{"key":"823_CR122","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10911-010-9163-3","volume":"15","author":"VA Spencer","year":"2010","unstructured":"Spencer VA, Xu R, Bissell MJ: Gene expression in the third dimension: the ECM-nucleus connection. J Mammary Gland Biol Neoplasia. 2010, 15: 65-71. 10.1007\/s10911-010-9163-3.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"823_CR123","doi-asserted-by":"publisher","first-page":"e59689","DOI":"10.1371\/journal.pone.0059689","volume":"8","author":"AC Luca","year":"2013","unstructured":"Luca AC, Mersch S, Deenen R, Schmidt S, Messner I, Sch\u00e4fer K-L, Baldus SE, Huckenbeck W, Piekorz RP, Knoefel WT, Krieg A, Stoecklein NH: Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One. 2013, 8: e59689-10.1371\/journal.pone.0059689.","journal-title":"PLoS One"},{"key":"823_CR124","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1040-8428(00)00078-0","volume":"36","author":"MT Santini","year":"2000","unstructured":"Santini MT, Rainaldi G, Indovina PL: Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol. 2000, 36: 75-87. 10.1016\/S1040-8428(00)00078-0.","journal-title":"Crit Rev Oncol Hematol"},{"key":"823_CR125","first-page":"838","volume":"54","author":"NS Waleh","year":"1994","unstructured":"Waleh NS, Gallo J, Grant TD, Murphy BJ, Kramer RH, Sutherland RM: Selective down-regulation of integrin receptors in spheroids of squamous cell carcinoma. Cancer Res. 1994, 54: 838-843.","journal-title":"Cancer Res"},{"key":"823_CR126","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/ijc.2910610613","volume":"61","author":"S Hauptmann","year":"1995","unstructured":"Hauptmann S, Denkert C, L\u00f6hrke H, Tietze L, Ott S, Klosterhalfen B, Mittermayer C: Integrin expression on colorectal tumor cells growing as monolayers, as multicellular tumor spheroids, or in nude mice. Int J Cancer. 1995, 61: 819-825. 10.1002\/ijc.2910610613.","journal-title":"Int J Cancer"},{"key":"823_CR127","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/1087057107306839","volume":"12","author":"J Friedrich","year":"2007","unstructured":"Friedrich J, Eder W, Castaneda J, Doss M, Huber E, Ebner R, Kunz-Schughart LA: A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assay. J Biomol Screen. 2007, 12: 925-937. 10.1177\/1087057107306839.","journal-title":"J Biomol Screen"},{"key":"823_CR128","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","volume":"148","author":"F Hirschhaeuser","year":"2010","unstructured":"Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA: Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol. 2010, 148: 3-15. 10.1016\/j.jbiotec.2010.01.012.","journal-title":"J Biotechnol"},{"key":"823_CR129","first-page":"4623","volume":"26","author":"N Fourr\u00e9","year":"2006","unstructured":"Fourr\u00e9 N, Millot J-M, Garnotel R, Jeannesson P: In situ analysis of doxorubicin uptake and cytotoxicity in a 3D culture model of human HT-1080 fibrosarcoma cells. Anticancer Res. 2006, 26: 4623-4626.","journal-title":"Anticancer Res"},{"key":"823_CR130","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bbrc.2013.03.008","volume":"433","author":"D Yip","year":"2013","unstructured":"Yip D, Cho CH: A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing. Biochem Biophys Res Commun. 2013, 433: 327-332. 10.1016\/j.bbrc.2013.03.008.","journal-title":"Biochem Biophys Res Commun"},{"key":"823_CR131","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1475-2867-10-26","volume":"10","author":"E Millerot-Serrurot","year":"2010","unstructured":"Millerot-Serrurot E, Guilbert M, Fourr\u00e9 N, Witkowski W, Said G, Van Gulick L, Terryn C, Zahm J-M, Garnotel R, Jeannesson P: 3D collagen type I matrix inhibits the antimigratory effect of doxorubicin. Cancer Cell Int. 2010, 10: 26-10.1186\/1475-2867-10-26.","journal-title":"Cancer Cell Int"},{"key":"823_CR132","doi-asserted-by":"publisher","first-page":"e53708","DOI":"10.1371\/journal.pone.0053708","volume":"8","author":"C Godugu","year":"2013","unstructured":"Godugu C, Patel AR, Desai U, Andey T, Sams A, Singh M: AlgiMatrixTM based 3D cell culture system as an in-vitro tumor model for anticancer studies. PLoS One. 2013, 8: e53708-10.1371\/journal.pone.0053708.","journal-title":"PLoS One"},{"key":"823_CR133","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","volume":"93","author":"JS Damiano","year":"1999","unstructured":"Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS: Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood. 1999, 93: 1658-1667.","journal-title":"Blood"},{"key":"823_CR134","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/10428190109057979","volume":"41","author":"F Sanz-Rodr\u00edguez","year":"2001","unstructured":"Sanz-Rodr\u00edguez F, Teixid\u00f3 J: VLA-4-dependent myeloma cell adhesion. Leuk Lymphoma. 2001, 41: 239-245. 10.3109\/10428190109057979.","journal-title":"Leuk Lymphoma"},{"key":"823_CR135","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1535-6108(02)00125-3","volume":"2","author":"VM Weaver","year":"2002","unstructured":"Weaver VM, Leli\u00e8vre S, Lakins JN, Chrenek MA, Jones JCR, Giancotti F, Werb Z, Bissell MJ: Beta4 Integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell. 2002, 2: 205-216. 10.1016\/S1535-6108(02)00125-3.","journal-title":"Cancer Cell"},{"key":"823_CR136","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2174\/092986708784049667","volume":"15","author":"R Schmidmaier","year":"2008","unstructured":"Schmidmaier R, Baumann P: ANTI-ADHESION evolves to a promising therapeutic concept in oncology. Curr Med Chem. 2008, 15: 978-990. 10.2174\/092986708784049667.","journal-title":"Curr Med Chem"},{"key":"823_CR137","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.drup.2009.08.001","volume":"12","author":"M-A Westhoff","year":"2009","unstructured":"Westhoff M-A, Fulda S: Adhesion-mediated apoptosis resistance in cancer. Drug Resist Updat. 2009, 12: 127-136. 10.1016\/j.drup.2009.08.001.","journal-title":"Drug Resist Updat"},{"key":"823_CR138","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2407-13-95","volume":"13","author":"P Longati","year":"2013","unstructured":"Longati P, Jia X, Eimer J, Wagman A, Witt M-R, Rehnmark S, Verbeke C, Toftg\u00e5rd R, L\u00f6hr M, Heuchel RL: 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer. 2013, 13: 95-10.1186\/1471-2407-13-95.","journal-title":"BMC Cancer"},{"key":"823_CR139","doi-asserted-by":"publisher","first-page":"8494","DOI":"10.1016\/j.biomaterials.2010.07.064","volume":"31","author":"D Loessner","year":"2010","unstructured":"Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, Rizzi SC: Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials. 2010, 31: 8494-8506. 10.1016\/j.biomaterials.2010.07.064.","journal-title":"Biomaterials"},{"key":"823_CR140","doi-asserted-by":"publisher","first-page":"e57056","DOI":"10.1371\/journal.pone.0057056","volume":"8","author":"Y Dong","year":"2013","unstructured":"Dong Y, Stephens C, Walpole C, Swedberg JE, Boyle GM, Parsons PG, McGuckin MA, Harris JM, Clements JA: Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment. PLoS One. 2013, 8: e57056-10.1371\/journal.pone.0057056.","journal-title":"PLoS One"},{"key":"823_CR141","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2121-14-7","volume":"14","author":"J Chen","year":"2013","unstructured":"Chen J, Wang J, Chen D, Yang J, Yang C, Zhang Y, Zhang H, Dou J: Evaluation of characteristics of CD44\u2009+\u2009CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures. BMC Cell Biol. 2013, 14: 7-10.1186\/1471-2121-14-7.","journal-title":"BMC Cell Biol"},{"key":"823_CR142","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1165\/rcmb.2008-0320OC","volume":"41","author":"T-M Yang","year":"2009","unstructured":"Yang T-M, Barbone D, Fennell DA, Broaddus VC: Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids. Am J Respir Cell Mol Biol. 2009, 41: 14-23. 10.1165\/rcmb.2008-0320OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"823_CR143","first-page":"73","volume":"24","author":"SY Lee","year":"2010","unstructured":"Lee SY, Jeong E, Jeon HM, Kim CH, Kang HS: Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids. Oncol Rep. 2010, 24: 73-79.","journal-title":"Oncol Rep"},{"key":"823_CR144","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1089\/adt.2010.0276","volume":"8","author":"VS Nirmalanandhan","year":"2010","unstructured":"Nirmalanandhan VS, Duren A, Hendricks P, Vielhauer G, Sittampalam GS: Activity of anticancer agents in a three-dimensional cell culture model. Assay Drug Dev Technol. 2010, 8: 581-590. 10.1089\/adt.2010.0276.","journal-title":"Assay Drug Dev Technol"},{"key":"823_CR145","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.bbrc.2007.01.159","volume":"355","author":"J Neuzil","year":"2007","unstructured":"Neuzil J, Stantic M, Zobalova R, Chladova J, Wang X, Prochazka L, Dong L, Andera L, Ralph SJ: Tumour-initiating cells vs. cancer \u201cstem\u201d cells and CD133: what\u2019s in the name?. Biochem Biophys Res Commun. 2007, 355: 855-859. 10.1016\/j.bbrc.2007.01.159.","journal-title":"Biochem Biophys Res Commun"},{"key":"823_CR146","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer. 2005, 5: 275-284. 10.1038\/nrc1590.","journal-title":"Nat Rev Cancer"},{"key":"823_CR147","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008, 8: 755-768. 10.1038\/nrc2499.","journal-title":"Nat Rev Cancer"},{"key":"823_CR148","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/stem.30","volume":"27","author":"S Takaishi","year":"2009","unstructured":"Takaishi S, Okumura T, Tu S, Wang SSW, Shibata W, Vigneshwaran R, Gordon SAK, Shimada Y, Wang TC: Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009, 27: 1006-1020. 10.1002\/stem.30.","journal-title":"Stem Cells"},{"key":"823_CR149","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ejcts.2009.03.063","volume":"36","author":"V Tirino","year":"2009","unstructured":"Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, Rocco G, Pirozzi G: The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg. 2009, 36: 446-453. 10.1016\/j.ejcts.2009.03.063.","journal-title":"Eur J Cardiothorac Surg"},{"key":"823_CR150","doi-asserted-by":"publisher","first-page":"e13943","DOI":"10.1371\/journal.pone.0013943","volume":"5","author":"O Awad","year":"2010","unstructured":"Awad O, Yustein JT, Shah P, Gul N, Katuri V, Neill AO, Kong Y, Brown ML, Toretsky JA, Loeb DM, O\u2019Neill A: High ALDH activity identifies chemotherapy-resistant Ewing\u2019s sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition. PLoS One. 2010, 5: e13943-10.1371\/journal.pone.0013943.","journal-title":"PLoS One"},{"key":"823_CR151","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1158\/0008-5472.CAN-07-6341","volume":"68","author":"L Moserle","year":"2008","unstructured":"Moserle L, Indraccolo S, Ghisi M, Frasson C, Fortunato E, Canevari S, Miotti S, Tosello V, Zamarchi R, Corradin A, Minuzzo S, Rossi E, Basso G, Amadori A: The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res. 2008, 68: 5658-5668. 10.1158\/0008-5472.CAN-07-6341.","journal-title":"Cancer Res"},{"key":"823_CR152","first-page":"683","volume":"2011","author":"AP Rybak","year":"1813","unstructured":"Rybak AP, He L, Kapoor A, Cutz J-C, Tang D: Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochim Biophys Acta. 1813, 2011: 683-694.","journal-title":"Biochim Biophys Acta"},{"key":"823_CR153","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.stem.2011.04.007","volume":"8","author":"E Pastrana","year":"2011","unstructured":"Pastrana E, Silva-Vargas V, Doetsch F: Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell. 2011, 8: 486-498. 10.1016\/j.stem.2011.04.007.","journal-title":"Cell Stem Cell"},{"key":"823_CR154","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1023\/B:HIJO.0000032354.94213.69","volume":"35","author":"R Marhaba","year":"2004","unstructured":"Marhaba R, Z\u00f6ller M: CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol. 2004, 35: 211-231.","journal-title":"J Mol Histol"},{"key":"823_CR155","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"ME Prince","year":"2007","unstructured":"Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007, 104: 973-978. 10.1073\/pnas.0610117104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"823_CR156","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1517\/17425255.4.6.697","volume":"4","author":"SA Marchitti","year":"2008","unstructured":"Marchitti SA, Brocker C, Stagos D, Vasiliou V: Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol. 2008, 4: 697-720. 10.1517\/17425255.4.6.697.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"823_CR157","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood.V87.3.1097.bloodjournal8731097","volume":"87","author":"M Magni","year":"1996","unstructured":"Magni M, Shammah S, Schir\u00f3 R, Mellado W, Dalla-Favera R, Gianni AM: Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood. 1996, 87: 1097-1103.","journal-title":"Blood"},{"key":"823_CR158","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00280-001-0412-4","volume":"49","author":"NE Sl\u00e1dek","year":"2002","unstructured":"Sl\u00e1dek NE, Kollander R, Sreerama L, Kiang DT: Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemother Pharmacol. 2002, 49: 309-321. 10.1007\/s00280-001-0412-4.","journal-title":"Cancer Chemother Pharmacol"},{"key":"823_CR159","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/sj.leu.2404721","volume":"21","author":"AMS Cheung","year":"2007","unstructured":"Cheung AMS, Wan TSK, Leung JCK, Chan LYY, Huang H, Kwong YL, Liang R, Leung AYH: Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD\/SCID engrafting potential. Leukemia. 2007, 21: 1423-1430. 10.1038\/sj.leu.2404721.","journal-title":"Leukemia"},{"key":"823_CR160","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007, 1: 555-567. 10.1016\/j.stem.2007.08.014.","journal-title":"Cell Stem Cell"},{"key":"823_CR161","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","volume":"10","author":"P Marcato","year":"2011","unstructured":"Marcato P, Dean CA, Giacomantonio CA, Lee PWK: Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle. 2011, 10: 1378-1384. 10.4161\/cc.10.9.15486.","journal-title":"Cell Cycle"},{"key":"823_CR162","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1590\/S0100-879X2012007500087","volume":"45","author":"M Ionta","year":"2012","unstructured":"Ionta M, Rosa MCC, Almeida RBB, Freitas VMM, Rezende-Teixeira P, Machado-Santelli GMM: Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation. Braz J Med Biol Res. 2012, 45: 721-729. 10.1590\/S0100-879X2012007500087.","journal-title":"Braz J Med Biol Res"},{"key":"823_CR163","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","volume":"183","author":"MA Goodell","year":"1996","unstructured":"Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996, 183: 1797-1806. 10.1084\/jem.183.4.1797.","journal-title":"J Exp Med"},{"key":"823_CR164","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1096\/fj.12-218222","volume":"27","author":"V Tirino","year":"2013","unstructured":"Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, La Noce M, Laino L, De Francesco F, Papaccio G: Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J. 2013, 27: 13-24. 10.1096\/fj.12-218222.","journal-title":"FASEB J"},{"key":"823_CR165","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.canlet.2013.01.021","volume":"332","author":"H Lee","year":"2013","unstructured":"Lee H, Park S, Kim JB, Kim J, Kim H: Entrapped doxorubicin nanoparticles for the treatment of metastatic anoikis-resistant cancer cells. Cancer Lett. 2013, 332: 110-119. 10.1016\/j.canlet.2013.01.021.","journal-title":"Cancer Lett"},{"key":"823_CR166","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1126\/science.1553558","volume":"255","author":"BA Reynolds","year":"1992","unstructured":"Reynolds BA, Weiss S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992, 255: 1707-1710. 10.1126\/science.1553558.","journal-title":"Science"},{"key":"823_CR167","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/resp.12094","volume":"18","author":"M Alamgeer","year":"2013","unstructured":"Alamgeer M, Peacock CD, Matsui W, Ganju V, Watkins DN: Cancer stem cells in lung cancer: evidence and controversies. Respirology. 2013, 18: 757-764. 10.1111\/resp.12094.","journal-title":"Respirology"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-33-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:50:34Z","timestamp":1746201034000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-33-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,28]]},"references-count":167,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-33-37","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,28]]},"assertion":[{"value":"6 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"37"}}